Status:

NOT_YET_RECRUITING

Blood Flow and Oxygenation in the Portal Vein in Subjects With Chronic Narrowing of the Blood Vessels to the Gut

Lead Sponsor:

Rigshospitalet, Denmark

Conditions:

Chronic Mesenteric Ischemia

Eligibility:

All Genders

18+ years

Brief Summary

In this study the investigators will, with an Magnetic Resonance Imaging (MRI) method, measure the oxygen content in the portal vein, which conduct the blood from the guts to the liver. Examinations w...

Detailed Description

Chronic mesenteric ischemia is a rare but potentially life threatening disease, in which atherosklerotic narrowing of the blood supply to the guts causes meal related abdominal pain, and subsequent we...

Eligibility Criteria

Inclusion

  • \- Written informed consent
  • Male or female persons \> 18 years
  • Subjects with postprandial abdominal pain considered compatible with mesenteric ischemia, and severe stenosis of the SMA and eventually other mesenteric arteries, diagnosed with CT-angiography or Doppler ultrasound
  • OR subjects with severe stenosis of the SMA and eventually other mesenteric arteries, diagnosed with CT-angiography or Doppler ultrasound, but not postprandial pain

Exclusion

  • \- Serious concurrent illness
  • BMI \> 30
  • Cardiac arrhythmia
  • Anemia with Hgb \< 7,0 mmol/l
  • Pregnancy or breastfeeding (urine HCG is performed on all fertile women)
  • Systolic blood pressure \< 90 or \> 200 mmHg
  • Claustrophobia
  • Patients who, in the judgement of the investigator, is incapable of participating
  • Metallic foreign objects in the body, or pacemakers

Key Trial Info

Start Date :

October 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 1 2028

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT07182669

Start Date

October 1 2025

End Date

October 1 2028

Last Update

September 19 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dept. of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet

Copenhagen, State, Denmark, 2100 Ø